The Investor’s Insider:
Protecting Against Securities Fraud

Posts Tagged ‘Settlement’

Pfizer to Pay $400M to Settle Shareholder Suit

Posted on: January 28th, 2015 by Nadine Gartner

Pharmaceutical company Pfizer Inc. has reached an agreement in principle to pay $400 million to settle a class-action securities lawsuit. Read more…

Pfizer Settles Class Action Lawsuit by Former Wyeth Shareholders

Posted on: November 15th, 2012 by Keith Dubanevich

Pfizer Inc. (“Pfizer”), the world’s largest pharmaceutical company, has agreed to pay $67.5 million to settle a class action lawsuit by shareholders of the former Wyeth Inc. (“Wyeth”), a pharmaceutical company bought by Pfizer in 2009.  Read more…

Pfizer to Pay $164 Million to Settle Celebrex Class Action

Posted on: October 16th, 2012 by Nadine Gartner

Pfizer Inc. has agreed to pay $164 million to settle a shareholder class action lawsuit involving Celebrex, an arthritis drug. Read more…

Largest Securities Class Action Lawsuit Settlement Due to Financial Crisis Announced

Posted on: October 9th, 2012 by Nadine Gartner

Bank of America recently announced a $2.43 billion deal to settle accusations that it misled investors about the acquisition of Merrill Lynch.  It is the largest securities class-action lawsuit settlement to arise from the financial crisis to date. Read more…

Legal Disclaimer

The information contained in this blog does not constitute legal advice, and does not create an attorney-client relationship. We make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this blog.

About this blog

The purpose of this blog is to provide information to the general public and to practitioners about developments that may impact Oregon investors.

About the author

  • Nadine Gartner

  • Nadine Gartner
  • Nadine Gartner’s practice focuses on complex business litigation and class actions. Prior to becoming a lawyer, Nadine worked as an investment banking analyst.
Follow stollberne on Twitter

Subscribe to this blog